Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
Currently approved therapies for age-related macular degeneration (AMD) are inhibitors against vascular endothelial growth factor (VEGF), which is a major contributor to the pathogenesis of neovascular AMD (nAMD). Intravitreal injections of anti-VEGF drugs have shown dramatic visual benefits for AMD...
Saved in:
Main Authors: | Yusaku Matsuda (Author), Yosuke Nonaka (Author), Satoshi Futakawa (Author), Hirotaka Imai (Author), Kazumasa Akita (Author), Toshiaki Nishihata (Author), Masatoshi Fujiwara (Author), Yusuf Ali (Author), Robert B. Bhisitkul (Author), Yoshikazu Nakamura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction
by: Denan Jin, et al.
Published: (2019) -
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy
by: Francesca Lazzara, et al.
Published: (2024) -
Antioxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Citrus lumia Juice
by: Antonella Smeriglio, et al.
Published: (2020) -
Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
by: Chimote G, et al.
Published: (2014) -
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
by: Chiara Bianca Maria Platania, et al.
Published: (2015)